Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Change in Cash (2016 - 2026)

Organogenesis Holdings has reported Change in Cash over the past 10 years, most recently at $30.0 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 27.33% year-over-year to $30.0 million; the TTM value through Dec 2025 reached -$41.8 million, down 231.46%, while the annual FY2025 figure was -$41.8 million, 231.46% down from the prior year.
  • Change in Cash for Q4 2025 was $30.0 million at Organogenesis Holdings, up from -$9.4 million in the prior quarter.
  • Over five years, Change in Cash peaked at $41.2 million in Q4 2024 and troughed at -$36.8 million in Q2 2025.
  • A 5-year average of $476250.0 and a median of $612000.0 in 2023 define the central range for Change in Cash.
  • Biggest five-year swings in Change in Cash: skyrocketed 1116.13% in 2024 and later tumbled 3353.67% in 2025.
  • Year by year, Change in Cash stood at $11.8 million in 2021, then plummeted by 140.08% to -$4.7 million in 2022, then skyrocketed by 216.53% to $5.5 million in 2023, then soared by 647.78% to $41.2 million in 2024, then dropped by 27.33% to $30.0 million in 2025.
  • Business Quant data shows Change in Cash for ORGO at $30.0 million in Q4 2025, -$9.4 million in Q3 2025, and -$36.8 million in Q2 2025.